Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0. The study record remains unavailable and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:32:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice announces that NIH is transitioning its terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:11:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-19T14:48:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:51.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the usual study content with an access-restricted notice and minimal navigation.
    Difference
    20%
    Check dated 2026-09-21T22:17:54.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the study page, signaling a new version of the document. This represents an update or correction to the page content reflected by the new revision number.
    Difference
    0.0%
    Check dated 2026-08-31T17:12:50.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.